Effect of Exercise Training on Physical, Cognitive, and Behavioral Function in People With TBI

Sponsor
National Institutes of Health Clinical Center (CC) (NIH)
Overall Status
Recruiting
CT.gov ID
NCT02504866
Collaborator
(none)
100
1
4
72.5
1.4

Study Details

Study Description

Brief Summary

Background:
  • Traumatic brain injury (TBI) often causes problems with moving and balance, and thinking and emotions. Exercise can improve these things in people with other brain damage. Researchers want to look at the effect of exercise on these things in people with TBI.
Objectives:
  • To study how head injuries affect the brain. To study if exercise can help some symptoms in people with TBI. These include problems thinking, balancing, and moving, and depression or anxiety.
Eligibility:
  • People age between 18 and 79 :

  • Had a non-penetrating TBI at least 12 months ago.

  • Are physically inactive, but can stand and walk without help.

Design:
  • Participants will be screened with medical history, physical exam, and blood and urine tests. They may have a balance test.

  • Participants will be assigned to a high-intensity or a lower-intensity exercise program.

  • The study is 6 months long. There will be 3 months with exercise on an elliptical machine and 3 months without exercise.

  • Participants will exercise for 30 minutes on an elliptical machine, 3 days per week for 3 months.

  • Participants will also have 3 outpatient testing visits lasting approximately 8 hours, once every 3 months. This visit will include:

  • Blood tests

  • Tests for memory, attention, and thinking

  • Tests of walking and balance

  • Questionnaires

  • An MRI: they will lie in a machine that takes pictures of their brain, while breathing regular air and air with more carbon dioxide

  • Test of physical fitness.

Condition or Disease Intervention/Treatment Phase
  • Other: Exercise
N/A

Detailed Description

Objective

The broad objective of this study is to examine the effects of moderate and more intense aerobic exercise as an intervention on cognitive performance, physical functioning and health-related quality of life in patients with chronic (more than 12 months post-injury) traumatic brain injury (TBI). Importantly, structural and biological brain changes will be measured to examine whether functional outcomes are related to exercise-induced adaptations. It is hypothesized that in the chronic phase of persons with TBI, there will be improved: 1) cognitive function, 2) physical fitness and fatigue severity, 3) motor performance and balance, and 4) mood and depressive symptoms, in those that performed the exercise intervention compared to a control group. It is also hypothesized that these functional improvements will be related to exercise intensity, improved cortical connectivity, dopamine transmission gene scores, and blood biomarkers related to neuroand angio-genesis.

Study Population

80 ambulatory adults with non-penetrating TBI will be enrolled. Subjects will be recruited from NIH, affiliated hospitals/clinics and the community.

Design

All subjects will perform baseline assessments including cognitive and behavioral performance, brain imaging, fitness, motor and balance testing, and selected blood and genetic testing. Thereafter, subjects will be randomized to either a waitlist control, or one of two exercise conditions: 1) 30 minutes at a fast pace, moderate-intensity (rapidresistive exercise; RET); 2) 30 minutes at higher-intensity (aerobic exercise; AET). Both exercise groups will perform the exercise on an elliptical trainer 3 times a week, for a session duration of 45 minutes including warm-up and cool-down. The RET group will focus on rapid reciprocal motion with minimal resistance, while the AET group will exercise at an elevated intensity known to produce an aerobic effect. After 12 weeks, all groups will repeat the baseline assessments (3 month follow-up). Following this assessment, the waitlist control group will be randomized to either RET or AET and the exercise groups will cease formal supervised exercise sessions. A third assessment visit will be performed after an additional 12 weeks (6 month follow-up).

Outcome Measures

Cognitive performance will be tested and interpreted compared to norms. Performance on motor and balance tasks will be assessed with the Smart Balance Measurement System and the GAITRite System. Physical fitness will be determined by peak oxygen consumption and aerobic threshold as measured by pulmonary gas exchange during an exercise tolerance test on the treadmill. Structural brain volumes will be determined by magnetic resonance imaging (MRI) and cortical connectivity will be quantified using resting state functional MRI and Diffusion Tensor Imaging (DTI) to evaluate integrity of and changes in white matter tracts in response to exercise. Blood will be collected to quantify the presence of biomarkers (such as VEGF, BDNF and IGF-1) and dopamine transmission. Other self-reported measures of quality of life, fatigue severity, depression and sleep quality would also be collected.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Effect of Exercise Training on Physical, Cognitive and Behavioral Function in Patients With Traumatic Brain Injury
Actual Study Start Date :
Dec 15, 2016
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: AET

Aerobic exercise will be performed on an elliptical trainer at a vigorous intensity

Other: Exercise
Exercise training of different intensity

No Intervention: Control

Wait-list control that performs no exercise for first 12 weeks; randomized to an exercise intervention (either AET or RET) after 12 weeks

No Intervention: Healthy Volunteer

Healthy volunteers will perform specific measures for a single study visit

Experimental: RET

Rapid reciprocal exercise will be performed on an elliptical trainer at light to moderate intensity

Other: Exercise
Exercise training of different intensity

Outcome Measures

Primary Outcome Measures

  1. Change in cognitive function (TMT-B) [Baseline, 3 months, 6 months]

    The difference in the time taken to complete the Trail Making Test B reflects the change in a subjects level of executive function.

Secondary Outcome Measures

  1. Change in motor assessment [Baseline, 3 months, 6 months]

  2. Change in cardiorespiratory fitness [Baseline, 3 months, 6 months]

  3. Change in fatigue [Baseline, 3 months, 6 months]

  4. Change in biomarkers [Baseline, 3 months, 6 months]

  5. Change in structural and functional measures (MRI) [Baseline, 3 months, 6 months]

  6. Change in other measures of cognitive function [Baseline, 3 months, 6 months]

  7. Comparison of imaging, biomarkers, cognitive and behavioral measures to healthy volunteers [Baseline]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
  • INCLUSION CRITERIA:
  1. Ages 18 to 79 inclusive

  2. Diagnosis of non-penetrating TBI

  3. Injury occurred at least 12 months prior to enrollment

  4. Physically inactive as identified by a physician

  5. Able to stand and walk independently and safely without any assistance

  6. Able to follow the study protocol

  7. Fluent in English and able to provide informed consent

EXCLUSION CRITERIA:
  1. History of exercise intolerance

  2. History of heart disease

  3. History of pulmonary disease, other than controlled, non-exercise-induced asthma

  4. History of uncontrolled diabetes

  5. Uncontrolled hypertension, defined as a resting blood pressure > 140/90 mmHg

  6. On medications that would influence aerobic capacity or treadmill performance such as beta blockers or antiretroviral therapy

  7. Active substance abuse including ETOH

  8. Presence of an injury to any extremity, or other medical condition that would affect motor function or the ability to perform the assessment or the exercise program, specifically balance problems due to vestibulopathy

  9. Unable to refrain from smoking at least 4 hours prior to exercise testing sessions

  10. Medical or psychological instability such that the subject could not reasonably be expected to fulfill the study requirements

  11. Pregnancy

  12. BMI >40 kg/M(2) due to the limits of the treadmill, elliptical machine and MRI scanner

  13. Planning to make a change in medication or therapy during the enrollment period with the goal of improving mood, cognitive function or motor function

  14. Have any of the following contraindications to having an MRI scan:

  15. A ventriculo-peritoneal shunt

  16. Have claustrophobia and not comfortable in small enclosed spaces

  17. Have metal that would make an MRI scan unsafe such as: cardiac pacemaker, insulin infusion pump, implanted drug infusion devise, cochlear or ear implant, transdermal medication patch (nitroglycerine), any metallic implants or objects, body piercing that cannot be removed, bone or joint pin, screw, nail, plate, wire sutures or surgical staples, shunts, cerebral aneurysms clips, shrapnel or other metal embedded (such as from war wounds or accidents or previous work in metal fields or machines that may have left any metallic fragments in or near your eyes).

  18. Excessive startle reaction to or fear of loud noises

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institutes of Health Clinical Center Bethesda Maryland United States 20892

Sponsors and Collaborators

  • National Institutes of Health Clinical Center (CC)

Investigators

  • Principal Investigator: Diane L Damiano, Ph.D., National Institutes of Health Clinical Center (CC)

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT02504866
Other Study ID Numbers:
  • 150164
  • 15-CC-0164
First Posted:
Jul 22, 2015
Last Update Posted:
Jul 7, 2022
Last Verified:
Mar 18, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by National Institutes of Health Clinical Center (CC)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2022